| KRAS Mutations in Primary Colorectal Cancer Tumors and Related Metastases: A Potential Role in Prediction of Lung Metastasis P Cejas, M Lopez-Gomez, C Aguayo, R Madero, J de Castro Carpeno, ... PloS one 4 (12), e8199, 2009 | 197 | 2009 |
| Differential colorectal carcinogenesis: Molecular basis and clinical relevance A Morán, P Ortega, C de Juan, T Fernández-Marcelo, C Frías, ... World journal of gastrointestinal oncology 2 (3), 151, 2010 | 166 | 2010 |
| Correlations of telomere length, telomerase activity, and telomeric‐repeat binding factor 1 expression in colorectal carcinoma: Prognostic indications C Garcia‐Aranda, C de Juan, A Diaz‐Lopez, A Sanchez‐Pernaute, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2006 | 128 | 2006 |
| Telomere shortening is associated with poor prognosis and telomerase activity correlates with DNA repair impairment in non-small cell lung cancer C Frías, C García-Aranda, C De Juan, A Morán, P Ortega, A Gómez, ... Lung cancer 60 (3), 416-425, 2008 | 125 | 2008 |
| Inhibition of telomerase activity preferentially targets aldehyde dehydrogenase-positive cancer stem-like cells in lung cancer D Serrano, AM Bleau, I Fernandez-Garcia, T Fernandez-Marcelo, ... Molecular cancer 10, 1-15, 2011 | 123 | 2011 |
| Biological and clinical significance of MMP-2, MMP-9, TIMP-1 and TIMP-2 in non-small cell lung cancer P Iniesta, A Morán, C De Juan, A Gómez, F Hernando, C García-Aranda, ... Oncology reports 17 (1), 217-223, 2007 | 102 | 2007 |
| Clinical relevance of MMP-9, MMP-2, TIMP-1 and TIMP-2 in colorectal cancer A Moran, P Iniesta, C Garcia-Aranda, C De Juan, A Díaz-López, ... Oncology reports 13 (1), 115-120, 2005 | 91 | 2005 |
| MMP-7 and SGCE as distinctive molecular factors in sporadic colorectal cancers from the mutator phenotype pathway P Ortega, A Moran, T Fernandez-Marcelo, C De Juan, C Frias, ... International journal of oncology 36 (5), 1209-1215, 2010 | 77 | 2010 |
| p53 exon 5 mutations as a prognostic indicator of shortened survival in non-small-cell lung cancer FJ Vega, P Iniesta, T Caldes, A Sanchez, JA Lopez, C De Juan, ... British journal of cancer 76 (1), 44-51, 1997 | 77 | 1997 |
| Clinical relevance of telomere status and telomerase activity in colorectal cancer T Fernández-Marcelo, A Sánchez-Pernaute, I Pascua, C De Juan, J Head, ... PloS one 11 (2), e0149626, 2016 | 74 | 2016 |
| Telomere length and telomerase activity in non-small cell lung cancer prognosis: clinical usefulness of a specific telomere status T Fernández-Marcelo, A Gómez, I Pascua, C de Juan, J Head, ... Journal of experimental & clinical cancer research 34, 1-7, 2015 | 62 | 2015 |
| Expression of MMP-9 and TIMP-1 as prognostic markers in gastric carcinoma. M de Mingo, A Morán, A Sanchez-Pernaute, P Iniesta, L Diez-Valladares, ... Hepato-gastroenterology 54 (73), 315-319, 2007 | 62 | 2007 |
| Cooperative Role of Telomerase Activity and p16 Expression in the Prognosis of Non–Small-Cell Lung Cancer R González-Quevedo, P Iniesta, A Morán, C de Juan, ... Journal of clinical oncology 20 (1), 254-262, 2002 | 58 | 2002 |
| Overexpression of SPARC protein contrasts with its transcriptional silencing by aberrant hypermethylation of SPARC CpG-rich region in endometrial carcinoma FJ Rodríguez-Jiménez, T Caldés, P Iniesta, JA Vidart, JL Garcia-Asenjo, ... Oncology reports 17 (6), 1301-1307, 2007 | 42 | 2007 |
| Differential prognosis of replication error phenotype and loss of heterozygosity in sporadic colorectal cancer MJ Massa, P Iniesta, R Gonzalez-Quevedo, C De Juan, T Caldes, ... European Journal of Cancer 35 (12), 1676-1682, 1999 | 40 | 1999 |
| Differential Wnt pathway gene expression and E-cadherin truncation in sporadic colorectal cancers with and without microsatellite instability P Ortega, A Morán, C de Juan, C Frías, S Hernández, JA López-Asenjo, ... Clinical cancer research 14 (4), 995-1001, 2008 | 38 | 2008 |
| Comparative survival analysis of p53 gene mutations and protein accumulation in colorectal cancer T Caldes, P Iniesta, FJ Vega, C de Juan, JA Lopez, E Diaz-Rubio, ... Oncology 55 (3), 249-257, 1998 | 38 | 1998 |
| Methylation profiling in non-small cell lung cancer: clinical implications A Moran, T Fernandez-Marcelo, J Carro, C De Juan, I Pascua, J Head, ... International journal of oncology 40 (3), 739-746, 2012 | 36 | 2012 |
| Differential impact of p16 inactivation by promoter methylation in non-small cell lung and colorectal cancer: clinical implications R González-Quevedo, C García-Aranda, A Morán, C De Juan, ... International journal of oncology 24 (2), 349-355, 2004 | 36 | 2004 |
| Stromelysin-1 promoter mutations impair gelatinase B activation in high microsatellite instability sporadic colorectal tumors A Morán, P Iniesta, C de Juan, R González-Quevedo, ... Cancer research 62 (13), 3855-3860, 2002 | 36 | 2002 |
